Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-027252
Filing Date
2025-02-25
Accepted
2025-02-25 21:30:04
Documents
1
Period of Report
2025-02-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3701
  Complete submission text file 0000950170-25-027252.txt   5130
Mailing Address C/O REPLIMUNE GROUP, INC. 18 COMMERCE WAY WOBURN MA 01801
Business Address
Weinand Dieter (Reporting) CIK: 0001744419 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41583 | Film No.: 25665822

Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Issuer) CIK: 0001835022 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)